Core Viewpoint - The collaboration between Peking University International Hospital and Baiyang Pharmaceutical aims to establish a "Precision Radiotherapy Center" utilizing the advanced ZAP-X brain precision radiotherapy robot, addressing the challenges of safety and precision in brain tumor treatments [2][3]. Group 1: Clinical Perspective - The relationship between doctors and tumors is characterized by the need to effectively eliminate the tumor while protecting normal tissues, highlighting the importance of precision and safety in brain radiotherapy [5]. - Traditional high-energy radiotherapy systems often lead to increased scatter risks, making it difficult for doctors to balance efficacy and side effects, which significantly impacts patient experience [6]. - The introduction of ZAP-X allows for a more humane treatment experience, reducing patient discomfort and treatment time while enhancing the confidence of doctors in delivering effective care [6][10]. Group 2: Collaborative Logic - The partnership between the hospital and the pharmaceutical company represents a genuine co-construction rather than a simple supplier-client relationship, focusing on mutual benefits and shared responsibilities [7][8]. - Baiyang Pharmaceutical, as a major stakeholder in ZAP Surgical, not only provides the equipment but also engages in clinical applications and validations, ensuring continuous improvement of the technology [10]. - The establishment of a high-end manufacturing base in Beijing aims to facilitate the domestic production and global delivery of ZAP-X, promoting the localization of advanced medical equipment [10]. Group 3: ZAP-X's Precision Control Logic - ZAP-X utilizes a 3MV linear accelerator, achieving a balance between sufficient energy and controllable energy levels, which minimizes scatter and enhances safety [14][15]. - The system's unique design allows for precise radiation delivery, significantly reducing the dose to healthy tissues and shortening treatment times by approximately 20% [15]. - The comfort and trust established through ZAP-X's technology enhance the overall treatment experience for both doctors and patients, making precision radiotherapy more accessible [15]. Group 4: Future Industry Perspective - The collaboration exemplifies a new medical cooperation ecosystem where both parties share the responsibility for validation and improvement, leveraging real clinical data for continuous optimization [16][17]. - The integration of precision and accessibility in brain radiotherapy transforms it from a high-end medical service to a routine treatment option [18]. - This co-construction model may set a new industry standard, where technology is not only introduced but also applied, validated, and iteratively improved [19][20].